Polypharmacy, defined as the use of multiple drugs or more than are medically necessary, is a growing concern for older adults. With older adults living longer and experiencing multiple chronic comorbidities, medication regimens are becoming increasingly complex and lengthy. It is not unusual to see patients taking 10 or more medications. Unfortunately, polypharmacy has been associated with an increased risk of adverse drug events (ADEs), drug-interactions, medication non-adherence, reduced functional capacity and multiple geriatric syndromes. This lecture will present real-world cases of polypharmacy and review the concepts of de-prescribing, what medications are no longer considered helpful to older adults, and how to safely reduce polypharmacy in real-world settings among patients.
PrimaryCareNOW: A Pri-Med Virtual Conference.
These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care, and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.
In recent years, many advances have occurred in the medical management of dermatologic disease. What's Poppin? will delve into the diagnosis and management of skin disorders seen commonly in primary care and will discuss updated therapeutic options.
Earn up to 3.25 AMA PRA Category 1 Credits during this virtual conference headlined by expert cardiologist Peter Libby, MD. This half-day of education is designed to provide you with cardiology-focused sessions, provide opportunities for interactive Q&A, and offer timely medical updates to keep you informed on the most current clinical strategies relevant to your daily practice.
What do primary care providers need to know to know about diabetes, atrial fibrillation, and mild cognitive impairment? Join endocrinologist Martin Abrahamson, cardiologist Ty Gluckman, and geriatrician Lee Lindquist as they review important questions, they get asked about these three topics!
A case of a woman with early symptoms of joint pains is presented and discussed as to what clinical, laboratory, imaging, and physical features will guide us to identify and distinguish between RA, psoriatic arthritis, SLE, and fibromyalgia. The key historical and clinical findings that distinguish these diseases are presented and the proper interpretation of imaging and tests like the ANA are reviewed.
Practice-changing updates to the medical literature that are hot off the presses! Join Dr. Pam Kushner to discuss important changes in the 2021 ADA guidelines and examine recently published research on atrial fibrillation, lipids, reducing cardiovascular risk, coconut oil, patient communication, and much more!
What do primary care providers need to know about migraine, movement disorders, dizziness, and vertigo? Join neurologists Patricia Greenstein, Daniel Press, and Rashmi Halker Singh as they review important questions they get asked about these topics!
Learn the impact of health disparities in communities of color. This presentation highlights the factors that contribute to health inequalities for Black, Hispanic and Native American communities. This includes a discussion of how social determinants of health has specifically impacted COVID-19. We will review racism as a social determinant of health and discuss how a historical perspective can provide further context into health disparities of communities of color. Implicit bias has been shown to play a role in health disparities. We will discuss strategies to help overcome implicit bias including perspective taking, cultural humility, and workforce diversity. Lastly, we’ll discuss how wellness can help achieve health equity.
Triglycerides and their management have received a great deal of publicity recently due to clinical trial results. Join Dr. Ty Gluckman as he reviews the risks associated with hypertriglyceridemia, discusses available therapeutic options to lower triglycerides, and reconciles the finding of the REDUCE-IT and the STRENGTH trials.